Science 37 - About the company
Science 37 is an acquired company based in Los Angeles (United States), founded in 2014 by Belinda Tan and Noah Craft. It operates as a Provider of a suite solution for clinical trials for researchers. Science 37 has raised $106M in funding from investors like Lux Capital, Redmile Group and Glynn Capital. The company has 320 active competitors, including 54 funded and 42 that have exited. Its top competitors include companies like Medidata, Verily and IQVIA.
Company Details
Science 37 offers end-to-end clinical trial solutions for researchers. Metasite, a clinical trial operating model of the company uses a mobile platform to allow patients to participate in the trial. The company has developed products like Science 37 Metasite that is a site-based clinical trial data collection on virtual media. The platform allows researchers to use the tool for trial management, data collection, and communication. The tool digital transformation allows users to study trail designing concepts and assist in virtualization. The tool provided by the company gives recruitment tools, patient enrollment system and more.
- Website
- science37.com
- Social
- Email ID
- *****@science37.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2014
Location
Los Angeles, United States
Stage
Acquired
Total Funding
$106M in 4 rounds
Latest Funding Round
Investors
Ranked
6th among 320 active competitors
Annual Revenue
$50M - $100M as on Dec 31, 2022
Employee Count
294 as on Aug 31, 2026
Exit Details
Acquired by eMedCare (Jan 29, 2024)
Legal entities associated with Science 37
Science 37 is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Science 37 Holdings, Inc. CIN: 1819113 , United States, Active | Apr 29, 2021 | $50M - $100M (As on Dec 31, 2022) | 460 (As on Dec 31, 2022) | - |
SCIENCE 37, INC. CIN: 471784711 , United States, Active | Sep 07, 2014 | - | 225 (As on Dec 31, 2024) | - |
Science 37's acquisition details
Click here to take a look at Science 37's acquisition in detail
Sign up to download Science 37's company profile
Science 37's funding and investors
Science 37 has raised a total funding of $106M over 4 rounds. Its first funding round was on Oct 20, 2015. Its latest funding round was a Series D round on Aug 20, 2020 for $*****. 10 investors participated in its latest round. Science 37 has 14 institutional investors.
Here is the list of recent funding rounds of Science 37:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 20, 2020 | 4387593 | Series D | 3898709 | 6498859 | 9299796 | 7955223 |
Apr 25, 2017 | 9989967 | Series C | 9596733 | 3673953 | 1435035 | |
Oct 18, 2016 | 9949617 | Series B | 6229100 | 6242664 |
Access funding benchmarks and valuations. Sign up today!View details of Science 37's funding rounds and investors
Science 37's founders and board of directors
Founder? Claim ProfileThe founders of Science 37 are Belinda Tan and Noah Craft.
Here are the details of Science 37's key team members:
- Belinda Tan: Former Co-Founder of Science 37.
- Noah Craft: Former Co-Founder of Science 37.
View details of Science 37's Founder profiles and Board Members
Science 37's employee count trend
Science 37 has 294 employees as of Aug 26. Here is Science 37's employee count trend over the years:
Uncover Science 37's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Science 37's Competitors and alternates
Top competitors of Science 37 include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of Science 37, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Medidata 1999, New York City (United States), Acquired | AI-based clinical trial management software for researchers | $41.5M | 86/100 | |
2nd |  Verily 2015, Dallas (United States), Series D | A data platform and technology company purpose-built to power AI-enabled precision health | $2.8B | 82/100 | |
3rd |  IQVIA 1982, Durham (United States), Public | Provider of clinical research and commercialization solutions for healthcare | $1.74M | 80/100 | |
4th |  Tempus 2015, Chicago (United States), Public | Developer of genomic testing and artificial intelligence tools for medicine | $1.05B | 77/100 | |
5th |  Signant Health 2000, Plymouth Meeting (United States), Acquired | Provider of a software solution for clinical trial management | $3.4M | 72/100 | |
6th |  Science 37 2014, Los Angeles (United States), Acquired | Provider of a suite solution for clinical trials for researchers | $106M | 70/100 | |
7th |  TriNetX 2013, Cambridge (United States), Acquired | Provider of clinical trial management software for researchers and professionals | $102M | 66/100 | |
8th | Wcg Clinical 2012, Princeton (United States), Acquired | CRO offering regulatory and ethical review services for clinical research | - | 64/100 | |
9th |  Obvio Health 2015, Orlando (United States), Series B | Provider of clinical trials design and recruitment platform | $66M | 62/100 | |
10th |  Autonomize 2021, Austin (United States), Series A | AI-based drug discovery tool for researchers | $32M | 61/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Science 37's competitors? Click here to see the top ones
Science 37's Investments and acquisitions
Science 37 has made no investments or acquisitions yet.
Reports related to Science 37
Here is the latest report on Science 37's sector:
News related to Science 37
Filter this listMedia has covered Science 37 for a total of 3 events in the last 1 year, 1 of them has been about partnerships and 1 about people movement.
•
PatientsLikeMe and Science 37 Partner to Unlock Trial AccessibilityGlobeNewswire•Jul 21, 2026•Science 37, PatientsLikeMe
•
Science 37 Appoints Kelly Johnston McKee as VP of Strategy & TransformationBenzinga•Jan 27, 2026•Science 37
•
Science 37 Completes Third FDA Inspection, Validating Accessibility & Quality in Phase 3 TrialGlobeNewswire•Oct 08, 2025•Science 37
•
Science 37 and Catalent Partner to Expand Clinical Research AccessibilityGlobeNewswire•Sep 04, 2025•Catalent, Science 37
•
Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access InnovationBenzinga•Jan 14, 2025•Science 37
•
Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease TrialGlobeNewswire•Nov 21, 2024•Science 37
•
Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NCGlobeNewswire•Aug 06, 2024•Science 37
•
Velocity appoints ex-IQVIA and Science 37 Executive Mike Zaranek as CFOBenzinga•Jul 16, 2024•Velocity Clinical Research, IQVIA, Science 37
•
Science 37 Quickly Impacts Performance in Under-Enrolling Clinical TrialsGlobeNewswire•Jun 27, 2024•Science 37
•
Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”GlobeNewswire•May 09, 2024•Science 37
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Science 37
Explore our recently published companies
- Primanindia - Unfunded company
- Dry Cargo - Colchester based, 1998 founded, Unfunded company
- Bay Area - Campbell based, Unfunded company
- Tabit / AgriGO - Sisli based, 2004 founded, Unfunded company
- CIE INTERNATIONAL - France based, Unfunded company
- United Seeds - Des Moines based, Unfunded company
